Ampicillin And Sulbactam Injection, Powder, For Solution
Product Images NDC 0409-2987

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ampicillin And Sulbactam (NDC 0409-2987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amp Sul Add V 01

FDA Label Image

Amp Sul Add V 02

FDA Label Image

Amp Sul Add V 03

FDA Label Image

Amp Sul Add V 04

FDA Label Image

Amp Sul Add V 05

FDA Label Image

Amp Sul Add V 06

Amp Sul Add V 06
This is a description of a medication with the NDC number 0408-2689-01. It is an antibiotic called Ampicillin and Sulbactam for Injection, USP. The medication comes in single-dose ADD-Vantage vials that contain 1.5g of the medication (equivalent to 1g of Ampicillin and 0.5g of Sulbactam). It is used for L.V. (low volume) injection and should be reconstituted only with ADD-Vantage Flexible Diluent Containers containing 0.9% Sodium Chloride injection. The medication should be administered within 8 hours of reconstitution and can only be used for IV purposes. The recommended dosage for adults is 1.5-3g every six hours, not exceeding 4g of Sulbactam per day.*
FDA Label Image

Amp Sul Add V 07

Amp Sul Add V 07
NDC 0409-2987-03 is a medication used for intravenous purposes only. It contains Ampicillin and Sulbactam and is sold in single-dose ADD-VantageĀ® vials. Each vial contains 3g Ampicillin and Subactam for Injection which is equivalent to 2g of Ampicillin plus 1g of Sulbactam. The usual adult dosage is 1.5g to 3g every six hours. The medication should be reconstituted with ADD-VantageĀ® Flexible Diluent Container containing 0.9% Sodium Chloride Injection. After reconstitution, the medication should be administered within 8 hours. The product is manufactured in Austria by Sandoz GmH for Hospira, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.